Provided by Tiger Fintech (Singapore) Pte. Ltd.

Puma Biotechnology

3.40
+0.04001.19%
Post-market: 3.400.00000.00%18:11 EDT
Volume:395.41K
Turnover:1.33M
Market Cap:168.77M
PE:4.40
High:3.42
Open:3.40
Low:3.34
Close:3.36
Loading ...

Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Zacks
·
21 Apr

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Apr

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
03 Apr

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.
·
28 Mar

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025

Business Wire
·
26 Mar

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now

Insider Monkey
·
18 Mar

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative

Simply Wall St.
·
07 Mar

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
06 Mar

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference

Business Wire
·
06 Mar

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

Zacks
·
03 Mar

Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook

TIPRANKS
·
01 Mar

Q4 2024 Puma Biotechnology Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Puma Biotechnology Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

GuruFocus.com
·
28 Feb

Puma Biotechnology Reports Strong Earnings Growth in 2024

TIPRANKS
·
28 Feb

Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects

TIPRANKS
·
28 Feb

Puma Biotech: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Puma Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Puma Biotechnology sees FY25 product revenue $192M-$198M

TIPRANKS
·
28 Feb

Puma Biotechnology Q4 Adj EPS $0.43 Beats $0.10 Estimate, Sales $59.10M Beat $52.50M Estimate

Benzinga
·
28 Feb